4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-053348
Sinha Vikas sold 2,707 shares at an average $1.56 ($4,220)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-19 | Sale : show line 1 in the form 10b5-1 | −1,232 | $1.58 | $1,947 | 1,171,714 | D |
| 2023-10-20 | Sale : show line 2 in the form 10b5-1 | −1,475 | $1.54 | $2,273 | 1,170,239 | D |
| Open-market sales · 2,707 sh · avg $1.56 · $4,220 | ||||||
Loading xslF345X05/doc4.xml…